A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia
BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by persistent, chronic inflammation that damages organ tissue. One of the symptoms that is often found in SLE is cognitive dysfunction. Hydroxychloroquine is recommended for the treatment of all levels of SLE. Th...
Автори: | Bantar Suntoko, Suharyo Hadisaputro, Handono Kalim, Suyanto Hadi, Ika Vemilia Warlisti |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Secretariat of The Indonesian Biomedical Journal
2023-08-01
|
Серія: | Indonesian Biomedical Journal |
Онлайн доступ: | https://inabj.org/index.php/ibj/article/view/2504 |
Схожі ресурси
Схожі ресурси
-
Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction
за авторством: Bantar Suntoko, та інші
Опубліковано: (2023-07-01) -
Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients
за авторством: Perdana Aditya Rahman, та інші
Опубліковано: (2022-05-01) -
Hyperuricemia and Pro Inflammatory Cytokine (IL-1β, IL-6, and TNF-α)
за авторством: Suyanto Hadi, та інші
Опубліковано: (2018-02-01) -
Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus
за авторством: Liu Peng-Cheng, та інші
Опубліковано: (2024-05-01) -
Periodontal Tissue Condition on Systemic Lupus Erythematosus Patients: A Clinical Study
за авторством: Nanda Rachmad Putra Gofur, та інші
Опубліковано: (2022-03-01)